RecruitingNot ApplicableNCT04986683

Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery

Novel DWI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery


Sponsor

Wayne State University

Enrollment

60 participants

Start Date

Aug 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability (i.e., functional deficit) and maximize surgical benefit probability (i.e., seizure freedom) by precisely localizing eloquent white matter pathways in children and adolescents with drug-resistant focal epilepsy. This new imaging approach, which will acquire a DWMRI scan before pediatric epilepsy surgery in about 10 minutes without contrast administration (and also without sedation even in young children), can be readily applied to improve preoperative benefit-risk evaluation for pediatric epilepsy surgery in the future. The investigators will also study how the advanced DWMRI-DCNN connectome approach can detect complex signs of brain neuronal reorganization that help improve neurological and cognitive outcomes following pediatric epilepsy surgery. This new imaging approach could benefit targeted interventions in the future to minimize neurocognitive deficits in affected children. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals. The findings of this project will not guide any clinical decision-making or clinical intervention until the studied approach is thoroughly validated.


Eligibility

Min Age: 3 YearsMax Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study uses advanced MRI brain imaging to map language, motor, and memory pathways in children with drug-resistant epilepsy who need brain surgery. The goal is to help surgeons avoid removing or damaging critical brain areas during epilepsy surgery, reducing the risk of post-surgery deficits in speech, movement, or cognition. You may be eligible if... - You are between 3 and 19 years old with drug-resistant focal epilepsy - You are scheduled for two-stage epilepsy surgery (with subdural electrode placement) - You are a healthy child between 5 and 19 years old (for the control group) You may NOT be eligible if... - You were born prematurely or had a perinatal brain injury from oxygen deprivation - You have hemiplegia (paralysis on one side of the body) - You have autism spectrum disorder, tic disorders, obsessive-compulsive disorder, or another developmental/psychiatric condition that clearly predates your seizures - You have severe claustrophobia - You have a massive brain malformation that would compromise imaging accuracy - You do not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBrain magnetic resonance imaging

Brain magnetic resonance imaging (MRI) will be done using multiple sequences to evaluate the presence, type, and severity of brain abnormalities in enrolled subjects.

BEHAVIORALNeuro-psychology testing

Participants will undergo age-appropriate neuro-psychology testing to assess motor, language, and other neurocognitive functions potentially affected by drug-resistant epilepsy.


Locations(1)

Wayne State University/Children's Hospital of Michigan

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04986683


Related Trials